{
    "id": "a4f2ab53-8687-4e56-aebf-fb0f906ac446",
    "indications": "ferrlecit indicated treatment iron deficiency anemia adult patients pediatric patients age 6 years older chronic kidney disease receiving hemodialysis receiving supplemental epoetin therapy .",
    "contraindications": "adult patients - recommended adult 10 ml ( 125 mg elemental iron ) diluted 100 ml 0.9 % sodium chloride administered intravenous infusion 1 hour per dialysis session undiluted slow intravenous injection ( rate 12.5 mg/min ) per dialysis session . ( 2.2 ) pediatric patients - recommended pediatric 0.12 ml/kg ( 1.5 mg/kg elemental iron ) diluted 25 ml 0.9 % sodium chloride administered intravenous infusion 1 hour per dialysis session . ( 2.3 ) mix ferrlecit medications add parenteral nutrition solutions intravenous infusion . administer 0.9 % saline . ( 2 )",
    "warningsAndPrecautions": "supplied ferrlecit clear , dark brown liquid supplied colorless glass vials . sterile , single-dose vial contains 62.5 mg elemental iron 5 ml intravenous . discard unused portion . carton containing 10 vials : ndc 0024-2792-10",
    "adverseReactions": "ferrlecit contraindicated patients known hypersensitivity sodium ferric gluconate components . included anaphylaxis [ ( 5.1 ) ] .",
    "ingredients": [
        {
            "name": "SODIUM FERRIC GLUCONATE COMPLEX",
            "code": "CC9149U2QX"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "organization": "sanofi-aventis  U.S. LLC",
    "name": "Ferrlecit",
    "effectiveTime": "20250522",
    "indications_original": "Ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy.",
    "contraindications_original": "Adult Patients - The recommended adult dosage is 10 mL (125 mg of elemental iron) diluted in 100 mL of 0.9% sodium chloride administered by intravenous infusion over 1 hour per dialysis session or undiluted as a slow intravenous injection (at a rate of up to 12.5 mg/min) per dialysis session. ( 2.2 ) Pediatric Patients - The recommended pediatric dosage is 0.12 mL/kg (1.5 mg/kg of elemental iron) diluted in 25 mL 0.9% sodium chloride and administered by intravenous infusion over 1 hour per dialysis session. ( 2.3 ) Do not mix Ferrlecit with other medications or add to parenteral nutrition solutions for intravenous infusion. Administer in 0.9% saline. ( 2 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  Ferrlecit is a clear, dark brown liquid supplied in colorless glass vials. Each sterile, single-dose vial contains 62.5 mg of elemental iron in 5 mL for intravenous use. Discard unused portion.\n                  Carton containing 10 vials: NDC 0024-2792-10",
    "adverseReactions_original": "Ferrlecit is contraindicated in patients with known hypersensitivity to sodium ferric gluconate or any of its components. Reactions have included anaphylaxis [see Warnings and Precautions (5.1)]."
}